A historic shift in Canadian drug policy has happened, as the regulators announce the availability of psilocybin hallucinogens for therapeutic treatment. Before this, these substances were strictly restricted, but a growing body of studies suggests they may offer relief for emotional conditions like depression. The new policy represents a key step